KCNQ1OT1 and diabetic cardiomyopathy: Yang et al. observed KCNQ1OT1 upregulation in patients with diabetes, high glucose-induced cardiomyocytes, and diabetic mouse cardiac tissue, and silencing KCNQ1OT1 inhibits diabetic cardiomyopathy [45].